Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Use of Multidrug Therapy Regimen for Hansen Disease Patients

Nawaz S. Mycobacterial Diseases. 2023; 13 (5) : 1.
Download PDF
Publication

Specialized active leprosy search strategies in an endemic area of the Brazilian Amazon identifies a hypermutated strain causing primary drug resistance.

Bouth R, Gobbo A, Barreto J, et al. Frontiers in medicine. 2023;
Download PDF
Publication

Basel: A Hotspot for Drug Discovery and Development Against Poverty-Related Diseases

Meier L. Swiss Chemical Society. CHIMIA. 2023; 77 (9) : 613.
Download PDF
Publication

Evolução do grau de incapacidade física e do escore olhos, mãos e pés em casos novos de hanseníase

Bomtempo CF, Ferrari SMF, Grossi MADF, et al. Instituto Lauro de Souza Lima. Hansenologia Internationalis: hanseníase e outras doenças infecciosas. 2023;
Download PDF
Publication

Hansen’s Disease with Pure Nerve Involvement and Perineural Abscess Mistaken for Peripheral Nerve Sheath Tumour

Sultan M, Choudhary M, Siddique M, et al. European Medical Group. EMJ Radiology. 2023;
Download PDF
Publication

Treatment of Hansen’s Disease

Florian MC, Deps PD. Springer International Publishing. Hansen’s Disease. 2023;
Publication

Epidemiology of Hansen’s Disease

Ignotti E, Steinmann P. Springer International Publishing. Hansen’s Disease. 2023;
Publication

The Journey to a Scientific Understanding of Leprosy: A Brief Outline

Scollard D. Springer International Publishing. Hansen’s Disease. 2023;
Publication

Introduction to Hansen’s Disease

Florian MC, Da Cunha Lopes Virmond M, Deps PD. Springer International Publishing. Hansen’s Disease. 2023;
Publication

Factors influencing adherence to treatment among people with leprosy in Costa Rica

Rivera Chavarría A, Sánchez Hernández G, Espinoza Aguirre A. Lepra. Leprosy Review. 2023; 94 (3) : 208-217.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 17
  • Next page ››
Subscribe to Multi-drug therapy (MDT)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD